03:21 AM EDT, 06/17/2025 (MT Newswires) -- Steve Elms, Director, on June 12, 2025, sold 425,621 shares in Adma Biologics ( ADMA ) for $8,829,333. Following the Form 4 filing with the SEC, Elms has control over a total of 2,119,060 common shares of the company, with 87,330 shares held directly and 2,031,730 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1368514/000114036125022713/xslF345X05/form4.xml